PEN · NYSE · STOCK
Penumbra (PEN) Stock Analysis
$320.99
52W $221.26 – $362.41
61/100
$12.65B
78.5
0.70
Is PEN Bullish or Bearish?
Bullish.
Innellis AI committee rates Penumbra, Inc. (PEN) Buy with a composite score of 61/100
, based on 6 analysts with 67% agreement.
Last updated October 16, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +13.88 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -6.12 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Risk Analyst sees a compelling case — low leverage (debt-to-equity 0.02) -- balance sheet can absorb a shock. Portfolio Manager remains cautious — sector concentration is already high (hhi 2739.42). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
- Low leverage (debt-to-equity 0.02) -- balance sheet can absorb a shock — Risk
- News sentiment is positive (+0.40 across 5 articles, 14d) — News
Bear Case
- P/E of 78.7 is expensive by classic value standards — Value
- Price-to-book of 8.5x prices in significant intangible value — Value
- 2 consecutive earnings misses -- execution concerns — Growth
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 16, 2026
Overall Committee Score
61/100
Agreement
67%
Analysts
6
Conviction
Moderate
Sector Rank
Top 25%
of 192 Healthcare peers
Value Analyst
bearish
40
/ 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− P/E of 78.7 is expensive by classic value standards
Growth Analyst
neutral
57
/ 100 · High confidence
Moderate growth -- present but not remarkable
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
− 2 consecutive earnings misses -- execution concerns
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ MACD histogram positive -- bullish momentum
Risk Analyst
bullish
73
/ 100 · Moderate confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
+ Low leverage (debt-to-equity 0.02) -- balance sheet can absorb a shock
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
70
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.40 across 5 articles, 14d)
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2739.42)
Investment Thesis Evolution
Committee score moved marginally from 61.7 to 61.1.
- New bearish signals: 2 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 2 signal(s) disappeared.
Analyst-level changes:
- News Analyst: score 74->70 (-3); +1 bullish signal(s).
- Portfolio Manager: +1 bearish signal(s).
- Value Analyst: +1 bearish signal(s).
Comparing 2026-10-15 to 2026-10-16 (1 day apart).
Technical Analysis
RSI (14)
68.9
Neutral
MACD Histogram
0.487
Bullish Momentum
Trend Direction
Sideways
Weekly: Sideways
Market Structure
Hh Hl
Support
$314.89
Resistance
$328.11
Bollinger %B
0.98
Inside Bands
Price vs Moving Averages
EMA 9
$319.55
Above
EMA 21
$319.31
Above
EMA 50
$320.05
Above
EMA 200
$315.77
Above
Fundamental Analysis
Valuation
0
Growth
52
Profitability
78
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio
78.5×
P/B Ratio
8.25×
PEG Ratio
11.57
Dividend Yield
0.00%
52W High
$362.41
52W Low
$221.26
Quality & Growth
ROE
1244.7%
ROA
972.8%
Gross Margin
6783.9%
Operating Margin
1244.9%
Revenue Growth YoY
—
Debt / Equity
0.14
AI Fundamental Assessment
P/E ratio of 78.5 (rich relative to a 15-40x range); Price-to-book of 8.2x; PEG ratio of 11.6 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 12.4%; Return on assets of 9.7%; Net margin of 10.7%; Gross margin of 67.8%; Current ratio of 5.75 (healthy short-term liquidity); Debt-to-equity of 0.14; Free cash flow per share is positive (5.49); Most recent quarter missed estimates by 26.6%; 2 consecutive earnings misses; EPS growth accelerating (-30.5% -> +7.3% QoQ); Average YoY EPS growth of 2.3%; Analyst estimates rising over recent quarters
Get the Full PEN Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →